Hello. Sign in to personalize your visit. New user? Register now.  
Journal of Palliative Medicine
Paracentesis in Ovarian Cancer: A Study of the Physiology during Free Drainage of Ascites

To cite this article:
Shandya Bridget Decruze, Robert Macdonald, Gillian Smith, Jonathan J. Herod. Journal of Palliative Medicine. -Not available-, ahead of print. doi:10.1089/jpm.2009.0158.

Online Ahead of Print: November 22, 2009

Full Text: • HTML • PDF for printing (2,621.4 KB) • PDF w/ links (80 KB)


Shandya Bridget Decruze, M.R.C.O.G.,
Robert Macdonald, M.D., M.R.C.O.G.,
Gillian Smith, M.Sc., and
Jonathan J. Herod, M.D., M.R.C.O.G.
Department of Gynaecological Oncology, Liverpool Womens NHS Foundation Trust, Liverpool, United Kingdom.
Address correspondence to:

Shandya Bridget Decruze, M.R.C.O.G

Department of Gynaecological Oncology

Liverpool Womens NHS Foundation Trust
Crown Street

Liverpool L8 7SS

United Kingdom
E-mail:
Accepted September 22, 2009

Abstract

Ascites is frequently seen in patients suffering with ovarian cancer. Paracentesis is a well-established method to provide symptomatic relief. Systemic adverse effects have occurred in paracentesis for ascites arising from other conditions. However, malignancy-related ascites has a different pathophysiology than nonmalignant ascites and as such the concerns related to the latter condition may not apply in patients with ovarian cancer. This study has shown that paracentesis is both effective and safe as an outpatient procedure for managing malignancy-related ascites.

Free first page
All articles
Previous Next